Avalon Healthcare Solutions and Sentara Health Plans Partner on Genetic Testing Management
Avalon Healthcare Solutions expanded its partnership with Sentara Health Plans for evidence-based genetic testing management services.
Read MorePosted by Andy Lundin | Jan 20, 2025 | Molecular Diagnostics |
Avalon Healthcare Solutions expanded its partnership with Sentara Health Plans for evidence-based genetic testing management services.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Lymphoma, Molecular Diagnostics |
Foresight Diagnostics’ ctDNA-MRD testing has been included in the NCCN Clinical Practice Guidelines for diffuse large B-cell lymphoma.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Hematology & Serology, Molecular Diagnostics |
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Read MorePosted by Andy Lundin | Jan 14, 2025 | Compliance |
Xifin’s CEO sees a window of opportunity for lawmakers to modify the Final Rule on LDTs that will be a win-win for the industry and patients.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Lung Cancer |
The ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read More